Study guide

10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans

BCSCP Board Certified Sterile Compounding Pharmacist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, USP Standards & CSP Categories

1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions

2 Chapter 2: Facilities, Engineering Controls & Cleaning

2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures

3 Chapter 3: Environmental Monitoring & Facility Certification

3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols

4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique

4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity

5 Chapter 5: Beyond-Use Dating, Storage & Container Rules

5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules

6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding

6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)

7 Chapter 7: Materials, Equipment & Compounding Workflow

7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs

8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility

8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics

9 Chapter 9: Therapeutics, Administration & Patient Monitoring

9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations

10 Chapter 10: Quality Management, Records & Personnel Competency

10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence

11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain

11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA

12 Chapter 12: Safety Management, Investigations, Recalls & Waste

12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management

10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans

Key Takeaways Explain This Topic AI

Gloved fingertip and thumb (GFT) sampling checks whether an operator can wash, garb and glove, and then work, without contaminating the gloves.

The initial garbing competency requires 3 separate, successive passes, each taken right after a full hand hygiene and garbing procedure, before sterile 70% IPA is applied, with an action level of > 0 CFU for both hands.

The garbing competency (visual observation plus GFT after garbing, still > 0 CFU) repeats at least every 6 months for Category 1 and 2 compounders and every 3 months for Category 3.

The > 3 CFU action level (both hands combined) applies only to the GFT taken inside the PEC immediately after a media-fill test, and failing it fails the whole aseptic manipulation competency.

Results and corrective actions are documented. The person must pass a reevaluation, defined by the facility's SOPs, before compounding again; USP does not require identification of GFT colonies.

Last updated: September 2026

Microbiological Foundations: Hands as the Primary Contamination Vector

In sterile compounding, touch contamination by gloved hands is the single most frequent mechanism of microbial transfer to critical sites. Even when cleanroom personnel wear sterile gloves, touching non-sterile equipment, clothing, masks, skin, or vial exteriors introduces microbial bioburden onto the glove surface. Subsequent contact with a sterile needle, syringe tip, or vial septum inoculates viable bacteria or fungi directly into the medication fluid path.

Gloved Fingertip and Thumb (GFT) sampling is the objective microbiological evaluation tool mandated by USP General Chapter <797> (2023 Revision) to measure an operator's competence in:

Performing correct hand hygiene and garbing without contaminating sterile gloves during donning.

Maintaining glove sterility and preventing touch contamination during active compounding manipulations.

  • Nutrient Media, Neutralizers & Sampling Mechanics
  • Culture Media Formulation

GFT sampling utilizes contact plates or flexible paddles filled with a sterile general microbiological nutrient agar, specifically:

Tryptic Soy Agar (TSA) , also known as Soybean-Casein Digest Agar (SCDA) .

The Critical Role of Chemical Neutralizers

USP <797> calls for sampling devices containing general growth media with neutralizing additives, for example:

  • Lecithin
  • Polysorbate 80 (Tween 80)

Important

Neutralizers are biochemically essential to prevent false-negative culture results . Cleanroom operators routinely use sanitizing agents, chlorhexidine hand soaps, and sterile 70% isopropyl alcohol. Trace residual antiseptics transferred from gloved fingers onto the agar surface would inhibit microbial growth and produce a false "negative" reading. Lecithin neutralizes quaternary ammonium compounds and chlorhexidine, while polysorbate 80 neutralizes phenols, hexachlorophene, and formalins, ensuring that any surviving viable microorganisms can successfully germinate into visible colonies.

Physical Sampling Mechanics

Digit Inclusion : All 10 digits —the pads of all four fingers and the thumb of both the right and left hands—must be sampled.

Plate Setup : Typically, one agar plate is dedicated to the left hand and a separate plate to the right hand (or a divided bi-plate).

Application Technique : The operator presses the pads of all 5 digits gently yet firmly into the nutrient agar surface for 3 to 5 seconds .

Pressure Control : Personnel must apply uniform, rolling pressure across each fingertip and thumb pad to ensure total surface contact without puncturing, cracking, or gouging the agar matrix.

Initial Qualification Protocol: The "Rule of Three"

Before any employee is permitted to compound sterile preparations independently, they must complete initial garbing competency and pass Initial Gloved Fingertip and Thumb Sampling .

The Golden Rule of Initial GFT: NO ALCOHOL!

Initial GFT sampling must be performed immediately after the operator completes the full hand hygiene and garbing sequence, inside the ante-room or cleanroom, but STRICTLY BEFORE applying sterile 70% IPA to the gloves !

Scientific Rationale : The initial GFT test evaluates the physical mechanics of hand washing and glove donning. If an operator applies sterile 70% IPA to their gloves prior to touching the agar, the alcohol will chemically eradicate any microorganisms transferred from skin, hair, or gowning materials during donning, producing a falsely sterile culture. The test must evaluate whether the operator can put on sterile gloves without contaminating them.

Initial Qualification Parameters

Number of Trials : The operator must complete 3 separate, consecutive successful trials .

Simulation Sequence : The individual must fully de-garb and re-execute the entire hand washing, garbing, and glove donning sequence 3 distinct times.

Passing Standard : 0 CFU total across both hands on ALL THREE trials !

Failure Threshold : Any microbial growth ( ≥ 1 CFU \ge 1\text{ CFU} ≥ 1 CFU ) on any finger or thumb in any of the three trials constitutes an immediate failure, requiring the entire 3-trial sequence to be restarted following retraining.

Ongoing Competency Cadence & Action Levels

USP <797> uses GFT in two ongoing evaluations with different action levels, and confusing them is a classic exam trap.

Cadence & Threshold Comparison Matrix

Parameter Initial garbing competency Ongoing garbing competency GFT after a media fill (aseptic manipulation competency)

Timing Right after garbing; before sterile 70% IPA Right after garbing; before sterile 70% IPA Inside the ISO Class 5 PEC , immediately after the media fill

How many 3 separate, successive passes 1 1, with the media fill and a surface sample of the direct compounding area

Frequency Before independent compounding At least every 6 months (Category 1 and 2) or 3 months (Category 3); every 12 months for non-compounding supervisors At least every 6 months (Category 1 and 2) or 3 months (Category 3)

  • Action level (both hands combined) > 0 CFU > 0 CFU > 3 CFU
  • Incubation Conditions & Reading

Plates are incubated as for environmental samples:

30 ∘ C to 35 ∘ C 30^\circ\text{C} \text{ to } 35^\circ\text{C} 3 0 ∘ C to 3 5 ∘ C for no less than 48 hours , for bacteria.

Then 20 ∘ C to 25 ∘ C 20^\circ\text{C} \text{ to } 25^\circ\text{C} 2 0 ∘ C to 2 5 ∘ C for no less than 5 additional days , for fungi.

Colonies on both hands are counted and added together.

The record must include the person's name, the date and time, the media and components used (manufacturer, expiration date and lot number), the starting temperature and dates of each incubation interval, the results, and who observed and who read them.

Remediation Protocol for GFT Excursions

If a garbing sample exceeds > 0 CFU , or a post-media-fill sample exceeds > 3 CFU , the evaluation has failed:

Stop Independent Compounding : The individual does not compound until requalified.

Identify the Cause : Review hand hygiene, garbing and gloving technique, glove handling during work, and the application of sterile 70% IPA. Identification of the colonies is not required by USP for GFT, but it can help. Skin flora suggest touch contamination, while spore-formers or Gram-negative rods point to the environment or water.

Document : USP requires the results and corrective actions to be documented, for a long-term record of competency.

Retrain : Targeted retraining in the deficient steps.

Reevaluate : The person must pass the reevaluation the SOPs define before compounding again. Many facilities repeat the three-evaluation initial series.